Five Prime Therapeutics Completes Phase 1 Safety Lead-In and Initiates Phase 3 Global Registrational Trial of Bemarituzumab
Homerun Resources Inc. Signs Commercial Letter of Intent with Jundu Ltda. for the Supply, Extraction and Primary Processing of High-Purity Silica Sand
